Q1 2024 Ocugen Inc Earnings Call Transcript
Good morning, and welcome to Ocugen's first quarter 2024 financial results and business update. Please note that this call is being recorded. (Operator Instructions)
I will now turn the call over to Tiffany Hamilton, Ocugen's Head of Corporate Communications. You may begin.
Thank you, operator, and good morning, everyone. Joining me on today's call and webcast is Dr. Shankar Musunuri, Ocugen's Chairman, CEO and Co-Founder, who provide a business update and an overview of our clinical and operational progress. Michael Breininger, our Corporate Controller, is also on the call to provide a financial update for the quarter ended March 31, 2024. Dr. Arun Upadhyay, Chief Scientific Officer, Head of Research and Development, and Dr. Huma Qamar, Chief Medical Officer, will be available to answer questions following the presentation.
This morning, we issued a press release detailing associated business and operational highlights for the first quarter of 2024. We encourage listeners to review the
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |